Cassaday & Co Wealth Management LLC Acquires Shares of 1,419 The Clorox Company (NYSE:CLX)

Cassaday & Co Wealth Management LLC bought a new position in The Clorox Company (NYSE:CLX) during the third quarter, Holdings Channel reports. The firm bought 1,419 shares of the company’s stock, valued at approximately $231,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. Mizuho Securities USA LLC boosted its position in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after acquiring an additional 4,490,421 shares during the last quarter. Van ECK Associates Corp grew its stake in shares of Clorox by 1,715.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after buying an additional 1,380,724 shares in the last quarter. Nuance Investments LLC increased its holdings in shares of Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after buying an additional 960,094 shares during the last quarter. Wulff Hansen & CO. raised its position in shares of Clorox by 13,547.0% during the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock valued at $60,063,000 after buying an additional 436,891 shares in the last quarter. Finally, International Assets Investment Management LLC lifted its holdings in shares of Clorox by 424.9% in the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after acquiring an additional 435,971 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

NYSE CLX opened at $169.14 on Tuesday. The company has a market cap of $20.94 billion, a PE ratio of 58.93, a P/E/G ratio of 3.10 and a beta of 0.41. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.21. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The firm’s 50 day moving average price is $162.53 and its 200-day moving average price is $147.73.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The firm’s quarterly revenue was up 27.0% compared to the same quarter last year. Sell-side analysts forecast that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 2.89%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Insiders Place Their Bets

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.57% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. DA Davidson increased their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and increased their price target for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, JPMorgan Chase & Co. boosted their price objective on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.